Future Drug Prices and Cost-Effectiveness Analyses

By Hoyle Martin  

PharmacoEconomics, Vol. 26, Iss. 7, 2008-01 ,pp. : 589-602

Adis International

Access to resources Recommend Favorite

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

By Phillips Kathryn A   Van Bebber Stephanie L  

Pharmacogenomics, Vol. 5, Iss. 8, 2004-12 ,pp. : 1139-1149

Future Medicine

Access to resources Recommend Favorite

The Importance of Cost Inputs and Sensitivity Analyses in a Cost-Effectiveness Analysis

By PharmD Jenna L. Yoder  

Clinical Drug Investigation, Vol. 28, Iss. 7, 2008-01 ,pp. : 461-462

Adis International

Access to resources Recommend Favorite

Valuing Health States for Use in Cost-Effectiveness Analysis

By Brazier John  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 769-779

Adis International

Access to resources Recommend Favorite

Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions: Why Uncertainty About the Outcome, Estimate and Willingness to Pay Matters

By Hoch Jeffrey S.   Dewa Carolyn S.  

PharmacoEconomics, Vol. 25, Iss. 10, 2007-01 ,pp. : 807-816

Adis International

Access to resources Recommend Favorite